Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Being able to practice on a model heart allows doctors to optimise the interventional procedure pre-operatively. 3D models can also be used to discuss the intervention with the medical team, patients and, in the case of congenital heart defects, with parents. It helps everyone affected to better understand what the procedure will involve
Vienna, Austria – 5 December 2014: New 3D printed heart technology could reduce the number of heart surgeries in children with congenital heart disease, according to Dr Peter Verschueren who spoke on the topic today at EuroEcho-Imaging 2014.1 Dr Verschueren brought 3D printed models of the heart to his lecture including models used to plan real cases in patients.EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC), and is held 3-6 December in Vienna, Austria.Dr Verschueren said:
“Children with congenital heart disease often need up to four open heart surgeries at different times of life. The 3D printed copy of the heart could reduce this to one or two because doctors can choose and practice the best interventional approach and device beforehand. This will avoid children spending months in intensive care.”
Three dimensional (3D) printing uses a machine to print objects layer by layer. Instead of ink the printer uses plastics, metals and other materials. The technology was first used in the automotive and aerospace industries to make prototypes. Dr Verschueren said: “You can make complex, unique things, which is useful in medicine because each patient is different.”3D printing entered the medical field around two decades ago in craniomaxillofacial and orthopaedic surgery. 3D reconstructions of a patient’s bone were made from a computed tomography (CT) scan. Today the technology is also used to make hearing aids. Printing 3D hearts was made possible with flexible materials for printing and fast scanners that can trace the beating heart. A CT or magnetic resonance imaging (MRI) scan is used to print muscles and valves which can be beating or static.The models are used to plan surgeries in children with congenital heart diseases such as double outlet right ventricle or Tetralogy of Fallot. Dr Verschueren said:
“Until recently, doctors would look at an image and then try to visualise the heart in 3D. Now they can use a 3D copy of an individual patient’s heart to plan the procedure in detail before they go into the operating theatre.”
“This is still a relatively new technology but there is increasing interest in using 3D printed models to plan heart valve interventions in adults. This could include complex bicuspid aortic valve cases that doctors want to treat with transcatheter aortic valve implantation (TAVI) and new transcatheter interventions for repairing or replacing the mitral and tricuspid valves.”
Today at EuroEcho-Imaging, biomedical research engineer Helen O' Grady from Galway, Ireland, presents a novel 3D printed model of tricuspid regurgitation she developed to test a new device and train interventionists in the implantation procedure.2 Ms O’Grady used CT scans of tricuspid regurgitation patients to build a 3D software model which she then used for 3D printing of a right heart and tricuspid valve annulus model..She took the additional step of using the 3D printed model to mould a more flexible model that is compatible with echocardiography and fluoroscopy. It is housed in a cardiac anatomy rig that replicates the anatomical conditions of the heart in the body as well as the leaflet motion of the valve. Doctors can use the model to practice implantation of the device on a patient’s exact anatomy before the procedure. Ms O’Grady, said:
“There is a variation in normal anatomies and more so in diseased anatomies such as tricuspid regurgitation. Being able to practice on the model allows for better surgical planning and doctors can optimise the interventional procedure pre-operatively. Cardiologists, surgeons and physicians say there’s nothing like having a tangible model in your hands as it gives such invaluable insight into the patient anatomy involved.”
“3D models can be used to discuss the intervention with the medical team, patients and, in the case of congenital heart defects, with parents. It helps everyone affected to better understand what the procedure will involve.”
Professor Patrizio Lancellotti, EACVI President, said: “3D imaging is a main theme of EuroEcho-Imaging this year and 3D printing of the heart is particularly exciting. It allows us to make a perfect model of a patient’s anatomy and decide the optimal device and procedure in advance.”ENDS
1Dr Peter Verschueren will give the talk ‘3D printing technology from cardiac imaging’ on 5 December in the session ‘The heart in 3D: new frontiers’ which starts at 08:30 CET. 2Helen O’Grady’s poster ‘Design of an echocardiographic bench-top test phantom replicating Tricuspid Regurgitation (TR)' will be on display on 5 December from 14:00 to 18:00 CET during Poster Session 5: Heart Valve Diseases. She will also have 3D models (GMedTech, GMIT, Galway, Ireland) on display.
The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. The European Association of Cardiovascular Imaging (formerly EAE) is a registered branch of the ESC. Its aim is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular ultrasound and other imaging modalities in Europe.EuroEcho-Imaging 2014 takes place during 3-6 December in Vienna, Austria, at the Reed Messe Wien GmbH congress centre. The full scientific programme is available here Press registration onsite requires a press card and signed embargo form.If you want to tweet about EuroEcho-Imaging, please use our hashtag: #euroecho
© 2017 European Society of Cardiology. All rights reserved